EP2839857A1 — Medicament dispenser
Assigned to Glaxo Group Ltd · Expires 2015-02-25 · 11y expired
What this patent protects
There is provided a medicament dispenser (600) for use with plural elongate form medicament carriers (601 a,b), each having multiple distinct medicament dose portions carried thereby, the dispenser having a dispensing mechanism for dispensing the distinct medicament dose portions…
USPTO Abstract
There is provided a medicament dispenser (600) for use with plural elongate form medicament carriers (601 a,b), each having multiple distinct medicament dose portions carried thereby, the dispenser having a dispensing mechanism for dispensing the distinct medicament dose portions carried by each of the plural medicament carriers. The mechanism comprises a receiving station (602a,b) for receiving each of the plural medicament carriers; a release for releasing a distinct medicament dose portion from each of the plural medicament carriers on receipt thereof by the receiving station; an outlet (624), positioned to be in communication with the distinct medicament dose portions releasable by said release; and an indexer (606a,b) for individually indexing the distinct medicament dose portions of each of the plural medicament carriers.
Drugs covered by this patent
- Cutivate (FLUTICASONE PROPIONATE) · Teva Pharm
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.